The NHS in England is set to roll out routine vaccinations against the respiratory syncytial virus (RSV) for pregnant women and older adults, starting on 1st September. This move aims to protect pregnant women and adults turning 75 from severe lung infections, with studies showing a 70% reduction in baby infections when pregnant women are vaccinated. The approval of the RSV vaccine by medicines regulators follows advice from the Joint Committee on Vaccination and Immunisation (JCVI).
RSV infections, particularly bronchiolitis, can lead to breathing and feeding difficulties in babies, causing around 20,000 hospital admissions annually in England. The vaccination program is expected to prevent thousands of hospitalizations and A&E visits for infants and older adults.
Mina Patel, a mother from Kent, emphasized the importance of the vaccine based on her daughter’s health struggles. With winter approaching, NHS Director Steve Russell encourages eligible individuals to take up the offer to protect themselves and others. This groundbreaking vaccine rollout is praised by health officials for its potential to save lives and alleviate pressure on the healthcare system during the winter season.
Source link